Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study-Reference-Cited by-同舟云学术

Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study

Published:2015-09 Issue:1 Volume:93 Page:141-149
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ohashi Toshio^ORCID,Yorozu Atsunori,Saito Shiro,Tanaka Nobumichi,Katayama Norihisa,Kojima Shinsuke,Maruo Shinichiro,Kikuchi Takashi,Dokiya Takushi,Fukushima Masanori,Yamanaka Hidetoshi

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group;Grimm;BJU Int,2012

2. Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center;Marshall;Urol Oncol,2014

3. Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer;Morris;Cancer,2013

4. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2011

5. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients;Crook;Int J Radiat Oncol Biol Phys,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer;Japanese Journal of Clinical Oncology;2024-08-28

2. Androgen Deprivation Benefits in Low-Dose-Rate Brachytherapy With Hydrogel Spacer;Cureus;2024-08-28

3. Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907);International Journal of Radiation Oncology*Biology*Physics;2024-02

4. Can Extreme Dose Escalation With External Beam Radiation Therapy and Low-Dose-Rate Brachytherapy Boost Obviate the Need for Long-Term Androgen Deprivation Therapy in Patients With High-Risk Localized Prostate Cancer?;International Journal of Radiation Oncology*Biology*Physics;2024-02

5. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry;Brachytherapy;2023-11